Germline mutations and prostate cancer: is it time to change treatment algorithms?

Abstract excerpt

Prostate cancer is the most commonly diagnosed non-skin cancer in men. Although early disease can be cured or remain indolent, advanced castration-resistant disease remains a significant cause of morbidity and mortality. One approach to precision screening may be the use of germline genetic testing. Mutations in high-risk genes such as BRCA 2 are rare however polygenic risk scores could potentially limit...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Algorithms
• Share to Genomics
• Share to Germ-Line Mutation